Efficacy and safety of anti-interleukin-6 treatment in familial Mediterranean fever: a systematic literature review

Introduction Biological treatments are indicated in familial Mediterranean fever (FMF) patients with colchicine resistance or intolerance. Interleukin-1 (IL-1) inhibitors may not yield sufficient efficacy and safety. Interleukin-6 inhibitors (tocilizumab – TCZ) have been suggested to be potentially...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Saidane Olfa, Selma Bouden, Ameni Jerbi, Leila Rouached, Ines Mahmoud, Rawdha Tekaya, Aicha Ben Tekaya, Leila Abdelmoula
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Termedia Publishing House 2025-11-01
סדרה:	Rheumatology
נושאים:	anti-il-6 colchicine resistance familial mediterranean fever fmf tocilizumab
גישה מקוונת:	https://reu.termedia.pl/Efficacy-and-safety-of-anti-interleukin-6-treatment-in-familial-Mediterranean-fever,199741,0,2.html
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!